arrow
D

David J. Douin

University of Colorado System
H指数:25
被引数:5,333

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Statistical analysis plan for the Strategy to Avoid Excessive Oxygen using Autonomous Oxygen Titration Intervention (SAVE-O2 AI) trial: protocol

使用自主氧调节干预策略避免过度氧疗试验(SAVE-O2 AI)的统计分析计划:方案

2026-01-280
OA
Ketamine or Etomidate for Tracheal Intubation of Critically Ill Adults

氯胺酮或依托咪酯用于危重症成人气管插管

2025-12-012
PRE
Targeted Normoxemia and Supplemental Oxygen-Free Days in Critically Injured Adults A Stepped-Wedge Cluster Randomized Clinical Trial

目标常氧血症及补充氧自由日在危重创伤成人中的研究——一项阶梯式群组随机临床试验

2025-03-310
OA
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants

感染SARS-CoV-2 α,δ 和Omicron变体的患者的总和亚基因组RNA病毒载量

2023-03-086
OA
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
2022-12-3111
OAAI
Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients

新型冠状病毒肺炎门诊患者接受中和单克隆抗体治疗后治疗失败与住院的关系

2022-11-073
OAAI
Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia
CHEST
IF8.6
2022-10-0115
OAAI
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial
2022-10-0166
OAAI
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

评估新型冠状病毒肺炎治疗试验的主要终点以评估恢复情况

2022-09-157
OAAI
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19: A Randomized Controlled Trial
2022-09-0117
OA